Clinical trial
A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive…
NCT00195845 · Cambridge Health Alliance, Other · Completed
Key facts
| NCT number | NCT00195845 |
|---|---|
| Title | A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder |
| Official title | A Phase 4 Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder |
| Lead sponsor | Cambridge Health Alliance, Other |
| Collaborators | Northwestern University |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Galantamine, Placebos |
| Enrollment | 30 |
| Start date | Apr 1, 2003 |
| Primary completion | Sep 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Apr 18, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: